Table of Contents
ISRN Critical Care
Volume 2013 (2013), Article ID 382015, 8 pages
http://dx.doi.org/10.5402/2013/382015
Clinical Study

Continuation or Discontinuation of Statin Therapy Did Not Influence Patient Outcomes after the Development of Acute Respiratory Distress Syndrome

1Department of Pharmacy, Cleveland Clinic, Cleveland, OH 44195, USA
2Respiratory Institute, Cleveland Clinic, Cleveland, OH 44195, USA

Received 20 November 2012; Accepted 18 December 2012

Academic Editors: H. Imanaka and S. J. Verbrugge

Copyright © 2013 Seth R. Bauer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. H. Goss, R. G. Brower, L. D. Hudson, and G. D. Rubenfeld, “Incidence of acute lung injury in the United States,” Critical Care Medicine, vol. 31, no. 6, pp. 1607–1611, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. L. D. Hudson, J. A. Milberg, D. Anardi, and R. J. Maunder, “Clinical risks for development of the acute respiratory distress syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 151, no. 2, part 1, pp. 293–301, 1995. View at Google Scholar · View at Scopus
  3. A. P. Wheeler and G. R. Bernard, “Acute lung injury and the acute respiratory distress syndrome: a clinical review,” The Lancet, vol. 369, no. 9572, pp. 1553–1564, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. “Ketoconazole for early treatment of acute lung injury and acute respiratory distress syndrome: a randomized controlled trial,” Journal of the American Medical Association, vol. 283, no. 15, pp. 1995–2002, 2000. View at Scopus
  5. “Randomized, placebo-controlled trial of lisofylline for early treatment of acute lung injury and acute respiratory distress syndrome,” Critical Care Medicine, vol. 30, no. 1, pp. 1–6, 2002.
  6. G. R. Bernard, J. M. Luce, C. L. Sprung et al., “High-dose corticosteroids in patients with the adult respiratory distress syndrome,” New England Journal of Medicine, vol. 317, no. 25, pp. 1565–1570, 1987. View at Google Scholar · View at Scopus
  7. G. U. Meduri, E. Golden, A. X. Freire et al., “Methylprednisolone infusion in early severe ards: results of a randomized controlled trial,” Chest, vol. 131, no. 4, pp. 954–963, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. G. U. Meduri, A. S. Headley, E. Golden et al., “Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial,” Journal of the American Medical Association, vol. 280, no. 2, pp. 159–165, 1998. View at Publisher · View at Google Scholar · View at Scopus
  9. K. P. Steinberg, L. D. Hudson, R. B. Goodman et al., “Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome,” New England Journal of Medicine, vol. 354, no. 16, pp. 1671–1684, 2006. View at Publisher · View at Google Scholar · View at Scopus
  10. D. Annane, V. Sébille, and E. Bellissant, “Effect of low doses of corticosteroids in septic shock patients with or without early acute respiratory distress syndrome,” Critical Care Medicine, vol. 34, no. 1, pp. 22–30, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. P. E. Marik, S. M. Pastores, D. Annane et al., “Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine,” Critical Care Medicine, vol. 36, no. 6, pp. 1937–1949, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. G. U. Meduri, P. E. Marik, S. M. Pastores, and D. Annane, “Corticosteroids in ARDS: a counterpoint,” Chest, vol. 132, no. 3, pp. 1093–1094, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. J. V. Peter, P. John, P. L. Graham, J. L. Moran, I. A. George, and A. Bersten, “Corticosteroids in the prevention and treatment of acute respiratory distress syndrome (ARDS) in adults: meta-analysis,” British Medical Journal, vol. 336, no. 7651, pp. 1006–1009, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. B. M. P. Tang, J. C. Craig, G. D. Eslick, I. Seppelt, and A. S. McLean, “Use of corticosteroids in acute lung injury and acute respiratory distress syndrome: a systematic review and meta-analysis,” Critical Care Medicine, vol. 37, no. 5, pp. 1594–1603, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. C. L. Hough, K. P. Steinberg, B. Taylor Thompson, G. D. Rubenfeld, and L. D. Hudson, “Intensive care unit-acquired neuromyopathy and corticosteroids in survivors of persistent ARDS,” Intensive Care Medicine, vol. 35, no. 1, pp. 63–68, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. W. Koenig, “Heart disease and the inflammatory response,” British Medical Journal, vol. 321, no. 7255, pp. 187–188, 2000. View at Google Scholar · View at Scopus
  17. L. M. Blanco-Colio, J. Tuñón, J. L. Martín-Ventura, and J. Egido, “Anti-inflammatory and immunomodulatory effects of statins,” Kidney International, vol. 63, no. 1, pp. 12–23, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. S. C. Tai, G. B. Robb, and P. A. Marsden, “Endothelial nitric oxide synthase: a new paradigm for gene regulation in the injured blood vessel,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 24, no. 3, pp. 405–412, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. I. I. Siempos, N. A. Maniatis, P. Kopterides et al., “Pretreatment with atorvastatin attenuates lung injury caused by high-stretch mechanical ventilation in an isolated rabbit lung model,” Critical Care Medicine, vol. 38, no. 5, pp. 1321–1328, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. H. W. Yao, L. G. Mao, and J. P. Zhu, “Protective effects of pravastatin in murine lipopolysaccharide-induced acute lung injury,” Clinical and Experimental Pharmacology and Physiology, vol. 33, no. 9, pp. 793–797, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. A. Pirat, P. Zeyneloglu, D. Aldemir et al., “Pretreatment with simvastatin reduces lung injury related to intestinal ischemia-reperfusion in rats,” Anesthesia and Analgesia, vol. 102, no. 1, pp. 225–232, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. B. Fessler, S. K. Young, S. Jeyaseelan et al., “A role for hydroxy-methylglutaryl coenzyme A reductase in pulmonary inflammation and host defense,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 6, pp. 606–615, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Shyamsundar, S. T. W. McKeown, C. M. O'Kane et al., “Simvastatin decreases lipopolysaccharide-induced pulmonary inflammation in healthy volunteers,” American Journal of Respiratory and Critical Care Medicine, vol. 179, no. 12, pp. 1107–1114, 2009. View at Publisher · View at Google Scholar · View at Scopus
  24. D. J. Kor, R. Iscimen, M. Yilmaz, M. J. Brown, D. R. Brown, and O. Gajic, “Statin administration did not influence the progression of lung injury or associated organ failures in a cohort of patients with acute lung injury,” Intensive Care Medicine, vol. 35, no. 6, pp. 1039–1046, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. T. R. Craig, M. J. Duffy, M. Shyamsundar et al., “A randomized clinical trial of hydroxymethylglutaryl-coenzyme a reductase inhibition for acute lung injury (the HARP study),” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 5, pp. 620–626, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. S. R. Bauer, S. W. Lam, and A. J. Reddy, “Effect of statin therapy on outcomes in patients with acute lung injury and acute respiratory distress syndrome,” American Journal of Respiratory and Critical Care Medicine, vol. 181, article A1701, 2010. View at Google Scholar
  27. H. P. Wiedemann, A. P. Wheeler, G. R. Bernard et al., “Comparison of two fluid-management strategies in acute lung injury,” New England Journal of Medicine, vol. 354, no. 24, pp. 2564–2575, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. D. A. Schoenfeld and G. R. Bernard, “Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndrome,” Critical Care Medicine, vol. 30, no. 8, pp. 1772–1777, 2002. View at Google Scholar · View at Scopus
  29. A. P. Liappis, V. L. Kan, C. G. Rochester, and G. L. Simon, “The effect of statins on mortality in patients with bacteremia,” Clinical Infectious Diseases, vol. 33, no. 8, pp. 1352–1357, 2001. View at Publisher · View at Google Scholar · View at Scopus
  30. P. Kruger, K. Fitzsimmons, D. Cook, M. Jones, and G. Nimmo, “Statin therapy is associated with fewer deaths in patients with bacteraemia,” Intensive Care Medicine, vol. 32, no. 1, pp. 75–79, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. R. W. Thomsen, A. Riis, J. B. Kornum, S. Christensen, S. P. Johnsen, and H. T. Sørensen, “Preadmission use of statins and outcomes after hospitalization with pneumonia population-based cohort study of 29 900 patients,” Archives of Internal Medicine, vol. 168, no. 19, pp. 2081–2087, 2008. View at Publisher · View at Google Scholar · View at Scopus
  32. E. M. Mortensen, M. I. Restrepo, A. Anzueto, and J. Pugh, “The effect of prior statin use on 30-day mortality for patients hospitalized with community-acquired pneumonia,” Respiratory Research, vol. 6, article 82, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. H. Schmidt, R. Hennen, A. Keller et al., “Association of statin therapy and increased survival in patients with multiple organ dysfunction syndrome,” Intensive Care Medicine, vol. 32, no. 8, pp. 1248–1251, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. P. P. Dobesh, D. G. Klepser, T. R. McGuire, C. W. Morgan, and K. M. Olsen, “Reduction in mortality associated with statin therapy in patients with severe sepsis,” Pharmacotherapy, vol. 29, no. 6, pp. 621–630, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. E. M. Mortensen, M. I. Restrepo, L. A. Copeland et al., “Impact of previous statin and angiotensin II receptor blocker use on mortality in patients hospitalized with sepsis,” Pharmacotherapy, vol. 27, no. 12, pp. 1619–1626, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. C. P. Martin, R. L. Talbert, D. S. Burgess, and J. I. Peters, “Effectiveness of statins in reducing the rate of severe sepsis: a retrospective evaluation,” Pharmacotherapy, vol. 27, no. 1, pp. 20–26, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Almog, A. Shefer, V. Novack et al., “Prior statin therapy is associated with a decreased rate of severe sepsis,” Circulation, vol. 110, no. 7, pp. 880–885, 2004. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Christensen, R. W. Thomsen, M. B. Johansen et al., “Preadmission statin use and one-year mortality among patients in intensive care—a cohort study,” Critical Care, vol. 14, no. 2, article R29, 2010. View at Publisher · View at Google Scholar · View at Scopus
  39. R. W. Thomsen, H. H. Hundborg, S. P. Johnsen et al., “Statin use and mortality within 180 days after bacteremia: a population-based cohort study,” Critical Care Medicine, vol. 34, no. 4, pp. 1080–1086, 2006. View at Publisher · View at Google Scholar · View at Scopus
  40. S. R. Majumdar, F. A. McAlister, D. T. Eurich, R. S. Padwal, and T. J. Marrie, “Statins and outcomes in patients admitted to hospital with community acquired pneumonia: population based prospective cohort study,” British Medical Journal, vol. 333, no. 7576, pp. 999–1001, 2006. View at Publisher · View at Google Scholar · View at Scopus
  41. K. C. Yang, J. Y. Chien, W. K. Tseng, P. R. Hsueh, C. J. Yu, and C. C. Wu, “Statins do not improve short-term survival in an oriental population with sepsis,” American Journal of Emergency Medicine, vol. 25, no. 5, pp. 494–501, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Fernandez, V. J. de Pedro, and A. Artigas, “Statin therapy prior to ICU admission: protection against infection or a severity marker?” Intensive Care Medicine, vol. 32, no. 1, pp. 160–164, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. I. M. Tleyjeh, T. Kashour, F. A. Hakim et al., “Statins for the prevention and treatment of infections: a systematic review and meta-analysis,” Archives of Internal Medicine, vol. 169, no. 18, pp. 1658–1667, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. Irish Critical Care Trials Group, “Acute lung injury and the acute respiratory distress syndrome in Ireland: a prospective audit of epidemiology and management,” Critical Care, vol. 12, no. 1, article R30, 2008. View at Google Scholar
  45. P. S. Kruger, N. M. Freir, B. Venkatesh, T. A. Robertson, M. S. Roberts, and M. Jones, “A preliminary study of atorvastatin plasma concentrations in critically ill patients with sepsis,” Intensive Care Medicine, vol. 35, no. 4, pp. 717–721, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. P. S. Kruger, M. L. Harward, M. A. Jones et al., “Continuation of statin therapy in patients with presumed infection: a randomized controlled trial,” American Journal of Respiratory and Critical Care Medicine, vol. 183, no. 6, pp. 774–781, 2011. View at Publisher · View at Google Scholar · View at Scopus
  47. M. Moss and D. M. Mannino, “Race and gender differences in acute respiratory distress syndrome deaths in the United States: an analysis of multiple-cause mortality data (1979–1996),” Critical Care Medicine, vol. 30, no. 8, pp. 1679–1685, 2002. View at Google Scholar · View at Scopus
  48. R. P. Dellinger, J. M. Carlet, H. Masur et al., “Surviving sepsis campaign guidelines for management of severe sepsis and septic shock,” Critical Care Medicine, vol. 32, no. 3, pp. 858–873, 2004. View at Publisher · View at Google Scholar
  49. R. B. D'Agostino Jr., “Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group,” Statistics in Medicine, vol. 17, no. 19, pp. 2265–2281, 1998. View at Google Scholar